The broad range goals of the proposed research involves development of MALDI Imaging Mass Spectrometry (IMS) to achieve (i) next generation improvements of the technology and associated methodologies for both profiling and imaging of tissues to gain significant improvements in speed, sensitivity and image resolution, (ii) development, testing, and validation of in situ chemistries for targeted analysis of specific proteins or families of proteins at high sensitivity, including in situ protein identification and (iii) applications of IMS to several biological research problems that can significantly benefit from this technology, e.g., addressing several fundamental questions in neurobiology, reproductive biology (embryo implantation), and drug distribution, toxicity and efficacy in intact organs and animal sections. More specifically, work proposed for technology and methodology improvements involve next generation enhancements for image acquisition speed, image resolution, and ease, robustness, and reproducibility of image acquisition. New sample preparation protocols will be devised to facilitate histology-directed molecular tissue analysis and to provide ease of 3-D protein image construction of tissue structures and small organs. Targeted analysis of proteins in tissues using in situ chemistries (tissue-based protein arrays) will be developed for the identification and quantitation of proteins directly in tissue sections. These include protocols that allow protease digestions in micron sized areas in tissue and the use of submicron particles having light cleavable linkers attached to molecular probes to remove and analyze proteins or families of proteins at very high sensitivity with spatially fidelity to the original tissue. Finally, these technologies and protocols will be applied to specific research problems to establish their efficacy in helping solve biological problems and provide spatially resolved molecular information. These applications will include problems in neurobiology, including studies in a mouse model of Parkinsonism, the creation of 3-D maps of mouse brain proteins, studies of embryo implantation in mouse, and applications to drug analysis, metabolism, and efficacy in studies in rat and mouse through tissue, organ, and whole body analyses. This research will provide a new technology for the discovery of molecular patterns in both health and disease. The elucidation of the spatial orientation of proteins in tissues and their quantitation and specific identification will answer many scientific questions about how disease might form and spread and will bring new insights into the prevention and treatment of human disease and the maintenance of human health. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM058008-10
Application #
7426326
Study Section
Enabling Bioanalytical and Biophysical Technologies Study Section (EBT)
Program Officer
Edmonds, Charles G
Project Start
1998-09-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
10
Fiscal Year
2008
Total Cost
$427,942
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Grove, Kerri J; Lareau, Nichole M; Voziyan, Paul A et al. (2018) Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney. Kidney Int 94:292-302
Chumbley, Chad W; Reyzer, Michelle L; Allen, Jamie L et al. (2016) Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues. Anal Chem 88:2392-8
Van Driest, Sara L; Marshall, Matthew D; Hachey, Brian et al. (2016) Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery. Br J Clin Pharmacol 81:1165-74
Anderson, David M G; Van de Plas, Raf; Rose, Kristie L et al. (2016) 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. J Proteomics 149:77-84
Zubair, Faizan; Laibinis, Paul E; Swisher, William G et al. (2016) Trypsin and MALDI matrix pre-coated targets simplify sample preparation for mapping proteomic distributions within biological tissues by imaging mass spectrometry. J Mass Spectrom 51:1168-1179
Marien, Eyra; Meister, Michael; Muley, Thomas et al. (2016) Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma. Oncotarget 7:12582-97
Spraggins, Jeffrey M; Rizzo, David G; Moore, Jessica L et al. (2016) Next-generation technologies for spatial proteomics: Integrating ultra-high speed MALDI-TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis. Proteomics 16:1678-89
Zavalin, Andre; Yang, Junhai; Hayden, Kevin et al. (2015) Tissue protein imaging at 1 ?m laser spot diameter for high spatial resolution and high imaging speed using transmission geometry MALDI TOF MS. Anal Bioanal Chem 407:2337-42
Marien, Eyra; Meister, Michael; Muley, Thomas et al. (2015) Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. Int J Cancer 137:1539-48
Prentice, Boone M; Chumbley, Chad W; Caprioli, Richard M (2015) High-speed MALDI MS/MS imaging mass spectrometry using continuous raster sampling. J Mass Spectrom 50:703-10

Showing the most recent 10 out of 161 publications